This past December, Prize4Life and the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital launched the PRO-ACT database (www.alsdatabase.org), which consists of over 8,500 ALS patient records from 17 completed Phase II and Phase III clinical trials conducted by companies including Sanofi, Novartis and Regeneron. In April, Prize4Life and NCRI were awarded the 2013 Best Practices Award in the Clinical & Health IT category from Bio-IT World for PRO-ACT. Click here to read about how merging multiple datasets from different clinical trials in PRO-ACT can be used to identify ways to “streamline clinical trials.” Also read about Prize4Life’s and NCRI’s plans to expand PRO-ACT, which includes potentially adding the data from the recent Phase III ALS clinical trials. With PRO-ACT continually expanding, there are many outstanding research questions that can now be addressed. Click here to learn about how you can use PRO-ACT to help advance ALS clinical research, and if you have an ALS clinical trial dataset that has not yet been included, PRO-ACT needs your data!
Click here to read more.Share this: